rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Susan Eylward

General Counsel and Corp Sec

Company insider

Files Form 4 as: General Counsel and Corp Sec, Imunon.

Every Form 4 they filed

In numbers

Trades disclosed
29
Buys
0
Sells
6
Bought
$0
Sold
$76K
Companies
1
Companies where not an officer
0
First trade
7 Oct 2024
Last trade
31 Aug 2026
Last filed
1 Sep 2026

Companies traded

Where they are an officer
IMNN ImunonOfficer · Biotechnology · last 31 Aug 20260 buys · 6 sells

Activity over time

1 Jun – 1 Oct
30Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Aug 2026filed 1 Sep 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9502,525 at $1.56filing
31 Aug 2026filed 1 Sep 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9392,525 at $1.56filing
28 Aug 2026filed 1 Sep 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0402,525 at $1.60filing
28 Aug 2026filed 1 Sep 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0402,525 at $1.60filing
17 Aug 2026filed 17 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9932,449 at $1.63filing
17 Aug 2026filed 17 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9922,449 at $1.63filing
14 Aug 2026filed 17 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0412,449 at $1.65filing
14 Aug 2026filed 17 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0412,449 at $1.65filing
3 Aug 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9772,541 at $1.57filing
3 Aug 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,9892,541 at $1.57filing
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0402,541 at $1.59filing
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$4,0402,541 at $1.59filing
20 Jul 2026filed 21 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,8302,150 at $1.78filing
20 Jul 2026filed 21 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$3,8272,150 at $1.78filing
17 Jul 2026filed 21 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$3,9352,150 at $1.83filing
17 Jul 2026filed 21 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$3,9352,150 at $1.83filing
6 Jul 2026filed 7 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$1,730920 at $1.88filing
6 Jul 2026filed 7 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Sold$1,730920 at $1.88filing
2 Jul 2026filed 7 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$1,757920 at $1.91filing
2 Jul 2026filed 7 Jul 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$1,757920 at $1.91filing

News

IMUNON To Sell ThermoDox Rights To VoxelDox For Glioblastoma MultiformeIMNN · rttnews.com · 21 Oct 2026

0 headlines in the last 90 days name Susan Eylward; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Douglas Vincent FallerChief Medical Officer · Chief Medical Officer at Imunon, filing Form 4 there in the last year
Michael H. TardugnoExecutive Chairman of Board · Executive Chairman of Board at Imunon, filing Form 4 there in the last year
Stacy LindborgPresident and CEO · President and CEO at Imunon, filing Form 4 there in the last year
Donald P. BraunDirector · Director at Imunon, filing Form 4 there in the last year
Christine A. PellizzariDirector · Director at Imunon, filing Form 4 there in the last year